亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 三肽-9抗糖化瓜氨酸Cas: 951775-32-9
三肽-9抗糖化瓜氨酸Cas: 951775-32-9
單價 10.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 10000g起訂1g
品牌 成都云希
CAS號 951775-32-9
外觀 白色粉末
HPLC 純度 ≥98%
過期 長期有效
更新 2021-07-05 16:42
 
詳細信息

1.Basic information:

INCI Name: Tripeptide-9 citrulline

Reference: dGlyage

Cas No: 951775-32-9

Formula:

Molecular:

Solubility: soluble in water

Stability: stable

Source: synthetic

Purity: ≧95%

MSDS and COA: available for your reference, please contact us.

Grade: cosmetic

Capacity: 100g per month

Appearance: white powder

 

 

2.Functions: Tripeptide-9 citrulline Reduces DNA damage resulting from fenton reaction products and reduces metal-mediated A.G.E. formation

 

3.Introduction: Tripeptide-9 citrulline prevents DNA structure changes triggered by transition metals.It chelates such ion metals that catalyse different reaction producing several DNA lesions.Miscrofluidised liposomes with diminished particle size contain the tetrapeptide,thus delivery to the skin is enchanced.

©2025 成都云希化工有限公司 版權所有   技術支持:化工網   訪問量:41515  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |